secwatch.observer — SEC 8-K summary
======================================

Issuer:     Forte Biosciences, Inc. (FBRX)
CIK:        0001419041
Form:       8-K
Filed at:   2025-06-25T23:59:59+00:00
Accession:  0001193125-25-147017
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Forte Biosciences prices $75M public offering of stock and warrants
-------------------------------------------------------------------

- Priced 5,630,450 shares at $12.00/share and 619,606 pre-funded warrants at $11.999/warrant.
- Gross proceeds expected ~$75M; net ~$70M (or ~$80.5M if underwriters' option exercised).
- Proceeds for working capital, general corporate purposes, funding clinical/preclinical development.
- Offering expected to close June 26, 2025, subject to customary closing conditions.
- Underwriters granted 30-day option to purchase up to 937,508 additional shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419041/000119312525147017/0001193125-25-147017-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419041/000119312525147017/d944948d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-147017

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer